Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer

By Dees E.   McKinnon Karen   Kuhns Jennifer   Chwastiak Kathryn   Sparks Scotty   Myers Mary   Collins Edward   Frelinger Jeffrey   Deventer Henrik   Collichio Frances   Carey Lisa   Brecher Mark   Graham Mark   Earp H.   Serody Jonathan  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 9, 2004-09 ,pp. : 777-785

Springer Publishing Company

Access to resources Recommend Favorite

In Vivo Anti-Tumor Effects of Flavokawain A in 4T1 Breast Cancer Cell-Challenged Mice

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 7, 2015-01 ,pp. : 905-915

Bentham Science Publishers

Access to resources Recommend Favorite

Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with antitumor activity against breast cancer in vivo

By Vigushin D.   Mirsaidi N.   Brooke G.   Sun C.   Pace P.   Inman L.   Moody C.   Coombes R.  

Medical Oncology, Vol. 21, Iss. 1, 2004-03 ,pp. : 21-30

Humana Press, Inc

Access to resources Recommend Favorite

COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro

By Du Ye   Shi Aiping   Han Bing   Li Sijie   Wu Di   Jia Hongyao   Zheng Chao   Ren Liqun   Fan Zhimin  

International Journal of Oncology, Vol. 44, Iss. 4, 2014-04 ,pp. : 1385-1393

Spandidos Publications

Access to resources Recommend Favorite

Telomere length of in vivo expanded CD4⁺CD25⁺ regulatory T-cells is preserved in cancer patients

By Wolf Dominik   Rumpold Holger   Koppelstätter Christian   Gastl Guenther   Steurer Michael   Mayer Gert   Gunsilius Eberhard   Tilg Herbert   Wolf Anna  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 10, 2006-10 ,pp. : 1198-1208

Springer Publishing Company

Access to resources Recommend Favorite